HRTX
Heron Therapeutics, Inc.
stockNASDAQ
At CloseOct 21, 2026 3:59:51 PM EDT
0.34USD-4.542%(-0.02)3,164,736
After-hoursOct 21, 2026 4:25:30 PM EDT
0.3334USD-1.478%(-0.005)
Loading…
Loading…
64.74M
Healthcare
Biotechnology
CEO
Barry Quart
HQ
San Diego, CA, USA
145
Previous Close
$0.35
Beta
1.68
52-Week High
$1.58 2026-01-09
52-Week Low
$0.26 2026-09-21
SMA 50
$0.33
SMA 200
$0.74
Avg. Vol 10D
2.11M
Avg. Vol 30D
2.34M
Avg. Vol 90D
2.71M
Relative Vol
1.30
189.85M
146.52M
77.18%
46,021,379
33.98%
17.30
37%/64%
54.74%
47.31%
2.3700%
5,500,000
210,633
83,297
210,633
Nov 3, 2026 (13d)
May 25, 2007 · 1-for-4 (reverse)
-34.0M
-12.1M
Oct 21, 2026
Top Performing High Short Interest Stocks · 
Benzinga
Oct 14, 2026
Notable Wednesday Option Activity: HRTX, GLNG, KNSL · 
BNK Invest
Sep 29, 2026
HRTX Profile
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
HRTX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.36 | 2026-10-14 | -5.80% | 3.170 |
| 1M | 0.27 | 2026-09-21 | +26.30% | 3.582 |
| 3M | 0.48 | 2026-07-21 | -28.54% | 1.013 |
| 6M | 1.02 | 2026-04-21 | -66.57% | 1.264 |
| 1Y | 1.30 | 2025-10-21 | -73.77% | 1.684 |
| 2Y | 1.81 | 2024-10-21 | -81.16% | — |
| 5Y | 10.17 | 2021-10-21 | -96.65% | 1.609 |
HRTX Stock Summary
Heron Therapeutics, Inc. (NASDAQ:HRTX) stock price today is $0.34, and today's volume is 3,028,613. HRTX is down 3.808% today. The 30 day average volume is 2.34M. HRTX market cap is $64.74M with 189.85M shares outstanding.